|

ACE-86225106 tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Acerand Therapeutics (Shanghai) Limited1

Indications

  • BRCA2 Mutation1
  • BRCA1 Mutation1
  • Ovarian Cancer1
  • Prostate Cancer1
  • Solid Tumor, Adult1

Other1 trial

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.